124 related articles for article (PubMed ID: 17317177)
1. Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors.
Keith JM; Gomez LA; Wolin RL; Barbier AJ; Wilson SJ; Boggs JD; Mazur C; Fraser IC; Lord B; Aluisio L; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 May; 17(9):2603-7. PubMed ID: 17317177
[TBL] [Abstract][Full Text] [Related]
2. Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitors.
Letavic MA; Keith JM; Ly KS; Barbier AJ; Boggs JD; Wilson SJ; Lord B; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 May; 17(9):2566-9. PubMed ID: 17307358
[TBL] [Abstract][Full Text] [Related]
3. Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.
Letavic MA; Keith JM; Jablonowski JA; Stocking EM; Gomez LA; Ly KS; Miller JM; Barbier AJ; Bonaventure P; Boggs JD; Wilson SJ; Miller KL; Lord B; McAllister HM; Tognarelli DJ; Wu J; Abad MC; Schubert C; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 Feb; 17(4):1047-51. PubMed ID: 17127059
[TBL] [Abstract][Full Text] [Related]
4. Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.
Letavic MA; Stocking EM; Barbier AJ; Bonaventure P; Boggs JD; Lord B; Miller KL; Wilson SJ; Carruthers NI
Bioorg Med Chem Lett; 2007 Sep; 17(17):4799-803. PubMed ID: 17616397
[TBL] [Abstract][Full Text] [Related]
5. Dual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophores.
Keith JM; Barbier AJ; Wilson SJ; Miller K; Boggs JD; Fraser IC; Mazur C; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 Oct; 17(19):5325-9. PubMed ID: 17765543
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of diamine-based histamine H3 antagonists with serotonin reuptake inhibitor activity.
Stocking EM; Miller JM; Barbier AJ; Wilson SJ; Boggs JD; McAllister HM; Wu J; Lovenberg TW; Carruthers NI; Wolin RL
Bioorg Med Chem Lett; 2007 Jun; 17(11):3130-5. PubMed ID: 17412583
[TBL] [Abstract][Full Text] [Related]
7. Exploration of structure-activity relationships for dual serotonin transporter reuptake inhibitors-histamine H3 receptor antagonists.
Stocking EM; Letavic MA; Bonaventure P; Carruthers NI
Curr Top Med Chem; 2010; 10(5):596-616. PubMed ID: 20166942
[TBL] [Abstract][Full Text] [Related]
8. Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitors.
Keith JM; Gomez LA; Barbier AJ; Wilson SJ; Boggs JD; Lord B; Mazur C; Aluisio L; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 Aug; 17(15):4374-7. PubMed ID: 17583504
[TBL] [Abstract][Full Text] [Related]
9. Dual serotonin transporter/histamine H3 ligands: Optimization of the H3 pharmacophore.
Keith JM; Gomez LA; Letavic MA; Ly KS; Jablonowski JA; Seierstad M; Barbier AJ; Wilson SJ; Boggs JD; Fraser IC; Mazur C; Lovenberg TW; Carruthers NI
Bioorg Med Chem Lett; 2007 Feb; 17(3):702-6. PubMed ID: 17107798
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of JNJ-28583867, a histamine H(3) receptor antagonist and serotonin reuptake inhibitor.
Barbier AJ; Aluisio L; Lord B; Qu Y; Wilson SJ; Boggs JD; Bonaventure P; Miller K; Fraser I; Dvorak L; Pudiak C; Dugovic C; Shelton J; Mazur C; Letavic MA; Carruthers NI; Lovenberg TW
Eur J Pharmacol; 2007 Dec; 576(1-3):43-54. PubMed ID: 17765221
[TBL] [Abstract][Full Text] [Related]
11. Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.
Middleton DS; Andrews M; Glossop P; Gymer G; Hepworth D; Jessiman A; Johnson PS; Mackenny M; Pitcher MJ; Rooker T; Stobie A; Tang K; Morgan P
Bioorg Med Chem Lett; 2008 Jul; 18(14):4018-21. PubMed ID: 18571404
[TBL] [Abstract][Full Text] [Related]
12. A new class of histamine H3 receptor antagonists derived from ligand based design.
Roche O; RodrÃguez Sarmiento RM
Bioorg Med Chem Lett; 2007 Jul; 17(13):3670-5. PubMed ID: 17498953
[TBL] [Abstract][Full Text] [Related]
13. Novel H3 receptor antagonists with improved pharmacokinetic profiles.
Santora VJ; Covel JA; Hayashi R; Hofilena BJ; Ibarra JB; Pulley MD; Weinhouse MI; Semple G; Ren A; Pereira G; Edwards JE; Suarez M; Frazer J; Thomsen W; Hauser E; Lorea J; Grottick AJ
Bioorg Med Chem Lett; 2008 Jul; 18(14):4133-6. PubMed ID: 18554904
[TBL] [Abstract][Full Text] [Related]
14. Novel 5-HT(1A/1B/1D) receptors antagonists with potent 5-HT reuptake inhibitory activity.
Serafinowska HT; Blaney FE; Lovell PJ; Merlo GG; Scott CM; Smith PW; Starr KR; Watson JM
Bioorg Med Chem Lett; 2008 Oct; 18(20):5581-5. PubMed ID: 18829312
[TBL] [Abstract][Full Text] [Related]
15. From histamine to imidazolylalkyl-sulfonamides: the design of a novel series of histamine H3-receptor antagonists.
Tozer MJ; Harper EA; Kalindjian SB; Pether MJ; Shankley NP; Watt GF
Bioorg Med Chem Lett; 1999 Jul; 9(13):1825-30. PubMed ID: 10406649
[TBL] [Abstract][Full Text] [Related]
16. N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.
Jonathan Fray M; Bish G; Brown AD; Fish PV; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2006 Aug; 16(16):4345-8. PubMed ID: 16750359
[TBL] [Abstract][Full Text] [Related]
17. 3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.
Vu AT; Cohn ST; Terefenko EA; Moore WJ; Zhang P; Mahaney PE; Trybulski EJ; Goljer I; Dooley R; Bray JA; Johnston GH; Leiter J; Deecher DC
Bioorg Med Chem Lett; 2009 May; 19(9):2464-7. PubMed ID: 19329313
[TBL] [Abstract][Full Text] [Related]
18. An investigation of the absolute configuration of the potent histamine H3 receptor antagonist GT-2331 using vibrational circular dichroism.
Minick DJ; Copley RC; Szewczyk JR; Rutkowske RD; Miller LA
Chirality; 2007 Sep; 19(9):731-40. PubMed ID: 17575572
[TBL] [Abstract][Full Text] [Related]
19. N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.
Fish PV; Fray MJ; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2007 Apr; 17(7):2022-5. PubMed ID: 17267217
[TBL] [Abstract][Full Text] [Related]
20. 4-[(1H-imidazol-4-yl) methyl] benzamidines and benzylamidines: novel antagonists of the histamine H3 receptor.
Aslanian R; Brown JE; Shih NY; wa Mutahi M; Green MJ; She S; Del Prado M; West R; Hey J
Bioorg Med Chem Lett; 1998 Aug; 8(16):2263-8. PubMed ID: 9873525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
